BD is paying $60M to settle Bard pelvic mesh suits with most U.S. states

BD is paying $60M to settle Bard pelvic mesh suits with most U.S. states

Source: 
Mass Device
snippet: 

Becton Dickinson (NYSE:BDX) will pay $60 million to 48 U.S. states to resolve allegations that its C.R. Bard business deceptively marketed transvaginal surgical mesh devices, state attorneys general in California and Washington announced Thursday.